DIABLO: from multi-omics assays to biomarker discovery, an integrative approach
Amrit Singh, Gautier, Benoit, Casey P. Shannon, Michael A. Vacher, Florian Rohart, Scott J Tebutt, Kim‐Anh Lê Cao
DIABLO identifies multi-omics biomarker panels to distinguish phenotypic groups, showing better biological enrichment than other methods in simulated and real datasets.
bioRxiv · Mar 20, 2018 · PreprintBioinformatics